GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Protia Inc (XKRX:303360) » Definitions » EBIT

Protia (XKRX:303360) EBIT : ₩1,351 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Protia EBIT?

Protia's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ₩413 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ₩1,351 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Protia's annualized ROC % for the quarter that ended in Sep. 2024 was 14.64%. Protia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 14.65%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Protia's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 6.13%.


Protia EBIT Historical Data

The historical data trend for Protia's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protia EBIT Chart

Protia Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial -1,268.68 -4,437.03 -769.32 1,277.80 501.07

Protia Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 468.69 19.12 97.48 821.27 412.68

Competitive Comparison of Protia's EBIT

For the Diagnostics & Research subindustry, Protia's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Protia's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Protia's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Protia's EV-to-EBIT falls into.



Protia EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,351 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Protia  (XKRX:303360) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Protia's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=2160.284 * ( 1 - 14.75% )/( (12161.5 + 13001.293)/ 2 )
=1841.64211/12581.3965
=14.64 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=26326.892 - 783.647 - ( 13381.745 - max(0, 1221.073 - 17881.066+13381.745))
=12161.5

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=26504.433 - 661.909 - ( 12841.231 - max(0, 1035.954 - 17453.46+12841.231))
=13001.293

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Protia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1650.716/( ( (7722.544 + max(3099.359, 0)) + (8396.544 + max(3311.49, 0)) )/ 2 )
=1650.716/( ( 10821.903 + 11708.034 )/ 2 )
=1650.716/11264.9685
=14.65 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(683.667 + 3051.713 + 482.405) - (783.647 + 0 + 334.779)
=3099.359

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(714.449 + 3336.008 + 226.459) - (661.909 + 0 + 303.517)
=3311.49

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Protia's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=1350.544/22016.009
=6.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Protia EBIT Related Terms

Thank you for viewing the detailed overview of Protia's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Protia Business Description

Traded in Other Exchanges
N/A
Address
Room 702, Building A, 401 Yangcheon-ro, Gangseo-gu, Seoul, KOR, 07528
Protia Inc is a South Korean company engaged in research and development, manufacturing and sales of in vitro diagnostic medical devices and diagnostic reagents. Their main product is allergy diagnostic products for humans and animals,' as well as various immunochemical in vitro diagnostic products.

Protia Headlines

No Headlines